MedAware vs VigiLanz (2026)
The same layering question as the rest of this segment, with a wider surveillance platform on one side. VigiLanz reaches across acute, post acute and ambulatory care, ingesting near real time data from any record system and firing alerts from rules the hospital configures itself. MedAware learns what a normal prescription looks like for a patient and flags the ones that do not fit, with independent Harvard led evaluation behind it, catching errors no rule was written to anticipate. A pharmacy running both will still get most of its alert volume from the rules, and most of its genuinely novel catches from the outlier model. The diligence questions differ accordingly: rule validation and retirement for one, subgroup performance for the other.
- The detection target is prescriptions that do not fit the patient, caught through outlier detection rather than through a rules library that must anticipate the hazard.
- Independent evaluation including a Harvard Medical School group, which is a stronger evidence position than anything in this segment.
- Integrations are confirmed by named customers rather than asserted, in both health system pharmacy and ambulatory workflows.
- Coverage is broadest by setting, spanning acute, post acute and ambulatory care, which suits a system that has grown beyond the hospital.
- Interoperability is the core competence, ingesting near real time clinical data regardless of which record system produced it.
- Rules are customer configurable, so the institution's own pharmacists own the alert logic and can read every criterion that fires.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. MedAware and VigiLanz are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | MedAware | VigiLanz |
|---|---|---|
| Primary category | Medication Safety & Prescribing | Medication Safety & Prescribing |
| Founded | 2012 | 2001 |
| Headquarters | Ra'anana, Israel | Minneapolis, Minnesota, United States |
| Website | medaware.com | inovalon.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards MedAware its top capability grade on AI Centrality. Set against VigiLanz, MedAware grades higher on AI Centrality and Clinical and Operational Evidence. Its thinnest published disclosure sits on several axes, including Model Supply Chain Disclosure, HIPAA and BAA Posture and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index records no top capability grade for VigiLanz on any axis it scores. Set against MedAware, VigiLanz grades higher on Model Supply Chain Disclosure. Its thinnest published disclosure sits on several axes, including AI Centrality, HIPAA and BAA Posture and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose MedAware or VigiLanz?
On the axes where the AI Health Index separates them, MedAware grades higher on AI Centrality and Clinical and Operational Evidence, and VigiLanz grades higher on Model Supply Chain Disclosure. MedAware leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do MedAware and VigiLanz differ most?
The widest separation the AI Health Index records between MedAware and VigiLanz is on AI Centrality, where MedAware grades A and VigiLanz grades D. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do MedAware and VigiLanz grade the same?
The AI Health Index grades MedAware and VigiLanz the same on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and AI Safety and PHI Stewardship. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have MedAware and VigiLanz not disclosed?
At the last review, at least one of MedAware and VigiLanz published thin or absent detail on several axes, including AI Centrality, Model Supply Chain Disclosure and HIPAA and BAA Posture. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both vendors describe their engines in AI terms and one of them is a rules engine, with a product page using the phrase flexible rule based AI, which is the clearest instance in this index of the label attaching to logic a hospital's own staff wrote. That is not a criticism, since a rules engine is transparent by construction, but it changes the diligence question from model accuracy to rule validation. VigiLanz publishes no located security attestation, trust centre or business associate terms. Neither publishes subgroup performance or pricing.